The study of the incidence of pregnant women with sickle cell disease


  • Jyoti Lagoo Department of Obstetrics and Gynecology, Lt. BRKMGMC, Jagdalpur, Chhattisgarh, India
  • Arpita Lagoo Department of Obstetrics and Gynecology, Lt. BRKMGMC, Jagdalpur, Chhattisgarh, India



Incidence, Pregnant women, Sickle cell disease


Background: The sickle cell disease is major public health problem which causes high morbidity and mortality in India. It is observed that SCD is scourge in Chhattisgarh since long past. Sickle cell disease is a term for a group of genetically inherited disorders characterized by production of abnormal hemoglobin. “Hemoglobin-S” results from a point mutation in the beta globin gene. The main objective is to study the incidence of pregnant women with sickle cell disease.

Methods: It is a hospital based prospective study. It was conducted at Obstetrics and Gynecology department of LTBRKM Govt. Medical College, Jagdalpur, Chhattisgarh. The study was carried out from August 2014 to October 2015. The study included screening of all patients attending antenatal clinic and in labour ward during emergency. 75 cases were found to be sickling positive. Permission from Institutional Ethics Committee was obtained.

Results: The incidence of SCD in India is 44%, in Chhattisgarh is 17%.At our institute in pregnant women is 1.75%. The incidence of HbAs group was 70.66% and HbSS was 26.66%. In Hb AS group maximum 47% patients were in age group of 26-30 years. and also in same age group the incidence of HbSS group was 60%. In age group of 31-35 years. 22% of patients were of HbAS group, but only 10% of patients were of HbSS group. HbAS group and HbSS group the percentage of primi gravida were 49% and 60% respectively. It is noted that in HbAS group only 3% of patients had parity >4, but in HbSS group it was 10%.

Conclusions: In conclusion, it has been shown that the clinical statuses of the most sickle cell diseases patience were not seriously affected by pregnancy if they are given appropriate prenatal care. All pregnant women should be screened for sickle sell hemoglobinopathy in endemic region, like in our state Chhattisgarh.


Stein Berg C, Jones JA, Detter JC. A Screening protocol for a prenatal population at risk for inherited hemoglobin disorders: result of its application to a group of Southeast Asians and blacks. Am J Obset Gynecol. 1984;150(4):333-41.

ACOG Technical bulletin. Hemoglobinopathies in pregnancy. Am College Obstet Gynecol. 1996;53(2):184-94.

Negi RS. The Incidence of sickle -cell Trait in Two Bastar Tribes. JSTOR.1962;62:84-6.

Gandhi SK, powers JC, nomeir AM. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-22.

Veille J, Hanson R. Left ventricular systolic and diastolic function is pregnant patients with sickle cell disease. Am J Obstet Gynecol. 1994;170(1):107-10.

Cunningham FG, Pritchard JA, Hankins GDV. Idiopathic cardiomyopathy or compounding cardio vascular events. Obstet Gynecol. 1986;67(2):157-68.

Eisenstein MI, Posner AC, Friedman S. Sickle cell anemia in pregnancy. A review of the literature with additional case histories. Am J Obstet Gynecol. 1956;72(3):622-34.

Harris JW. Aggravation of clinical manifestations of folic acid deficiency by small daily doses of vitamin B12. Arch Int Med. 1956;21(3):461-7.

Huck EV. Sickle cell anemia. Arch Intern Med. 1927;39(2):233-54.

Ley TJ, Demimonde J, Anagnou N. 5-Azacytidine selectively increases T-globin synthesis in a patient with Thalassemia. N Engl J Med. 1982;307(24):1469-75.






Original Research Articles